Literature DB >> 6187750

Chemotactic activity of platelet alpha granule proteins for fibroblasts.

R M Senior, G L Griffin, J S Huang, D A Walz, T F Deuel.   

Abstract

At sites of blood vessel injury, platelets release numerous substances that may have biological activities influencing cellular responses. In this study we examined separately the chemotactic activity for fibroblasts of three highly purified proteins obtained from platelet alpha granules: platelet factor 4 (PF4), platelet-derived growth factor (PDGF), and beta-thromboglobulin (BTG). We observed that each of these proteins was strongly chemotactic for fibroblasts, with maximum chemotactic activity in each instance comparable to that observed with an optimal concentration of the control chemotactic protein, plasma fibronectin. Each protein was active at very low concentrations. The peak chemotactic activities of PF4, PDGF, and BTG occurred at 200 mg/ml, 30 ng/ml, and 6 ng/ml, respectively. Specificity of fibroblast chemotaxis to individual platelet proteins was provided by finding that anti-PF4 immunoglobulin blocked the chemotactic activity of PF4 without affecting the chemotactic activity of PDGF, while anti-PDGF immunoglobulin blocked the activity of PDGF but did not alter the capacity of PF4 to promote fibroblast chemotaxis. These results suggest that in vivo several alpha granule proteins released from platelets may affect wound healing by causing directed fibroblast migration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187750      PMCID: PMC2112304          DOI: 10.1083/jcb.96.2.382

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  22 in total

1.  Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides.

Authors:  A E Postlethwaite; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Human beta-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells.

Authors:  W Hope; T J Martin; C N Chesterman; F J Morgan
Journal:  Nature       Date:  1979-11-08       Impact factor: 49.962

3.  Generation of a fibroblast chemotactic factor in serum by activation of complement.

Authors:  A E Postlethwaite; R Snyderman; A H Kang
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

4.  Development of a radioimmunoassay for human platelet factor 4.

Authors:  S P Levine; L S Krentz
Journal:  Thromb Res       Date:  1977-11       Impact factor: 3.944

Review 5.  Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

Authors:  K L Kaplan; J Owen
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

6.  Vascular permeation of platelet factor 4 after endothelial injury.

Authors:  I D Goldberg; M B Stemerman; R I Handin
Journal:  Science       Date:  1980-08-01       Impact factor: 47.728

7.  Platelet alpha-granule proteins: studies on release and subcellular localization.

Authors:  K L Kaplan; M J Broekman; A Chernoff; G R Lesznik; M Drillings
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

8.  Complete covalent structure of human beta-thromboglobulin.

Authors:  G S Begg; D S Pepper; C N Chesterman; F J Morgan
Journal:  Biochemistry       Date:  1978-05-02       Impact factor: 3.162

9.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

10.  The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor.

Authors:  A E Postlethwaite; R Snyderman; A H Kang
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  61 in total

1.  Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development.

Authors:  J R Crosby; K A Tappan; R A Seifert; D F Bowen-Pope
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury.

Authors:  Bernard S Buetow; Kristen A Tappan; Jeffrey R Crosby; Ronald A Seifert; Daniel F Bowen-Pope
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

3.  Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site.

Authors:  A D Luster; J V Ravetch
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

4.  Monocyte-derived CXCL7 peptides in the marrow microenvironment.

Authors:  Manoj M Pillai; Mineo Iwata; Norihiro Awaya; Lynn Graf; Beverly Torok-Storb
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

5.  De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor.

Authors:  R K Khouri; S P Hong; E G Deune; J E Tarpley; S Z Song; C M Serdar; G F Pierce
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes.

Authors:  A Siegbahn; A Hammacher; B Westermark; C H Heldin
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 7.  Protein factors which regulate cell motility.

Authors:  E M Rosen; I D Goldberg
Journal:  In Vitro Cell Dev Biol       Date:  1989-12

8.  Production of platelet-derived growth factorlike protein by rat mesangial cells in culture.

Authors:  H E Abboud; E Poptic; P DiCorleto
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling.

Authors:  Boleslaw K Winiarski; Katarzyna I Wolanska; Srijana Rai; Tahanver Ahmed; Nigel Acheson; Nicholas J Gutowski; Jacqueline L Whatmore
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.